Wayne Nicholls

Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1–2 trial

Birgit Geoerger, Hyoung Jin Kang, Michal Yalon-Oren et al. · The Lancet Oncology · 2019 · 343 citations

Medicine, Oncology, Pharmacotherapy +17

Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)

Amar Gajjar, Giles Robinson, Kyle Smith et al. · Journal of Clinical Oncology · 2021 · 236 citations · Full text

Medicine, Oncology, Pediatrics +17

Precision-guided treatment in high-risk pediatric cancers

Loretta M. S. Lau, Dong-Anh Khuong-Quang, Chelsea Mayoh et al. · Nature Medicine · 2024 · 69 citations · Full text

Medicine, Oncology, Pediatrics +16

Agenesis of the corpus callosum and gray matter heterotopia in three patients with constitutional mismatch repair deficiency syndrome

Annette F. Baas, Michael T. Gabbett, Milan Rimac et al. · European Journal of Human Genetics · 2012 · 49 citations · Full text

Medicine, Neurology, Pathology +11

Inconsistencies and time delays in site‐specific research approvals hinder collaborative clinical research in Australia

Victoria White, Helen Bibby, Monica Green et al. · Internal Medicine Journal · 2016 · 32 citations · Full text

Public Health, Oncology, Ethics +16